comprehensive -WSS

comprehensive

author：leisure time 2025-09-06 02:10:30 - browse：599

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The health care issue Democrats can’t solve: hospital reform

focus

WSS

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Kidney transplant patients stopped immunosuppressants in trial

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Kidney transplant patients stopped immunosuppressants in trial

Coloradans with cystic fibrosis could lose access to Trikafta

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

explore

comprehensive

hotspot

What does generative AI mean for health care? We asked experts

Analysis of telehealth claims data suggest service duplication

What does generative AI mean for health care? We asked experts

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Trump demands the U.S. pay no more for drugs than other countries … again

A Q&A with the global head of Boehringer Ingelheim's innovation unit

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What is microchimerism and how does it affect maternal health?

explore

Infant mortality in U.S. rose last year for first time in decades: CDC

FDA rejects Alnylam's heart disease treatment over insufficient data

Sana to lay off nearly a third of staff, de

Prime Medicine says its gene editing passes test in monkeys

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Liquid biopsy for lung cancer is launched by Delfi

leisure time

focus

entertainment

explore